Dave DeGreeff focuses his entire practice on civil litigation with an emphasis on complex pharmaceutical/medical device actions and catastrophic personal injury. Dave has successfully represented clients in all aspects of litigation, up to and through trial.
Dave is currently involved in representing clients injured by numerous pharmaceutical drugs and medical devices, including, among others, the prescription hypertension drug olmesartan (brand names Benicar, Benicar HCT, Azor and Tribenzor), prescription testosterone replacement therapy drugs (brand names AndroGel, Testim, Axiron, Androderm, Testopel, Fortesa, Depo-Testosterone, Striant and Delatestryl), and the medical devices commonly known as inferior vena cava filters. In addition to his product liability work, Dave continues to handle catastrophic personal injury and wrongful death cases.
Dave has represented thousands of injured plaintiffs in pharmaceutical and product liability cases. His current involvement in multi-district pharmaceutical and medical device litigation includes:
Member of Science and Experts committee and in charge of Secondary Science Document Review In re Benicar (Olmesartan) Products Liability Litigation, MDL 2606 (D. NJ)
Member of Medical Monitoring Class Action committee In re Bard Filters Product Liability Litigation, MDL 2641 (D. Ariz.)
Member of Plaintiff’s Steering Committee In re Cook Medical, Inc., IVC Filters Marketing, Sales and Products Liability Litigation, MDL 2570 (S.D. Ind.)